RS50370B - N-(heterociklil)benzen-ili-piridinsulfonamidi kao antitrombički i antikoagulirajući agensi - Google Patents

N-(heterociklil)benzen-ili-piridinsulfonamidi kao antitrombički i antikoagulirajući agensi

Info

Publication number
RS50370B
RS50370B YUP-670/02A YUP67002A RS50370B RS 50370 B RS50370 B RS 50370B YU P67002 A YUP67002 A YU P67002A RS 50370 B RS50370 B RS 50370B
Authority
RS
Serbia
Prior art keywords
group
amino
alkyl
carbonyl
optionally substituted
Prior art date
Application number
YUP-670/02A
Other languages
English (en)
Serbian (sr)
Inventor
Jean-Michael ALTENBURGER
Gerard Cremer
Gilbert LASSALLE
Mostafa MATROUGUI
Original Assignee
Sanofi-Aventis,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis, filed Critical Sanofi-Aventis,
Priority to MEP-174/08A priority Critical patent/MEP17408A/xx
Publication of YU67002A publication Critical patent/YU67002A/sh
Publication of RS50370B publication Critical patent/RS50370B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
YUP-670/02A 2000-03-23 2001-03-22 N-(heterociklil)benzen-ili-piridinsulfonamidi kao antitrombički i antikoagulirajući agensi RS50370B (sr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MEP-174/08A MEP17408A (en) 2000-03-23 2001-03-22 N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0003724A FR2806722B1 (fr) 2000-03-23 2000-03-23 Derives de n-(heterocyclylbutyl) benzene-ou pyridine sulfonamide, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
YU67002A YU67002A (sh) 2005-07-19
RS50370B true RS50370B (sr) 2009-11-10

Family

ID=8848428

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-670/02A RS50370B (sr) 2000-03-23 2001-03-22 N-(heterociklil)benzen-ili-piridinsulfonamidi kao antitrombički i antikoagulirajući agensi

Country Status (34)

Country Link
US (1) US6680329B2 (enExample)
EP (1) EP1268469B1 (enExample)
JP (1) JP2003528098A (enExample)
KR (1) KR100791693B1 (enExample)
CN (1) CN1183128C (enExample)
AR (1) AR029900A1 (enExample)
AT (1) ATE269325T1 (enExample)
AU (2) AU4661701A (enExample)
BG (1) BG65863B1 (enExample)
BR (1) BR0109385A (enExample)
CA (1) CA2401637C (enExample)
DE (1) DE60103868T2 (enExample)
DK (1) DK1268469T3 (enExample)
EA (1) EA004986B1 (enExample)
EE (1) EE05084B1 (enExample)
ES (1) ES2222358T3 (enExample)
FR (1) FR2806722B1 (enExample)
HR (1) HRP20020762B1 (enExample)
HU (1) HUP0300695A2 (enExample)
IL (2) IL151619A0 (enExample)
IS (1) IS2304B (enExample)
ME (1) MEP17408A (enExample)
MX (1) MXPA02009276A (enExample)
NO (1) NO324835B1 (enExample)
PL (1) PL204660B1 (enExample)
PT (1) PT1268469E (enExample)
RS (1) RS50370B (enExample)
SI (1) SI1268469T1 (enExample)
SK (1) SK286687B6 (enExample)
TR (1) TR200402343T4 (enExample)
TW (1) TWI290141B (enExample)
UA (1) UA71667C2 (enExample)
WO (1) WO2001070736A1 (enExample)
ZA (1) ZA200206996B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4903385B2 (ja) 2002-12-06 2012-03-28 パーデュー・リサーチ・ファウンデーション 損傷した哺乳類神経組織を治療するためのピリジン類
US8729107B2 (en) * 2002-12-06 2014-05-20 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
WO2005102991A1 (ja) * 2004-04-19 2005-11-03 Daiso Co., Ltd. 非天然型アミノ酸の製造方法およびその中間体
US7750162B2 (en) 2004-04-19 2010-07-06 Daiso Co., Ltd. Process for preparation of nonnatural amino acid and intermediate thereof
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
JP5492189B2 (ja) * 2008-04-09 2014-05-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ccr10アンタゴニストである2−スルホニルアミノ−4−ヘテロアリールブチロアミド
US8859814B2 (en) * 2008-05-22 2014-10-14 Boehringer Ingelheim International Gmbh Alpha-substituted N-sulfonyl gylcine amides antagonists of CCR10, compositions containing the same and methods for using them
BR112012019042A8 (pt) * 2010-01-28 2017-12-26 The Medicines Company Leipzig Gmbh compostos inibidores de serina protease tipo tripsina, seu uso, e seus processos de preparação
FR2981071B1 (fr) * 2011-10-10 2014-02-07 Centre Nat Rech Scient Synthese versatile et stereospecifique d'acides amines gamma,delta-insatures par la reaction de wittig

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2727410B1 (fr) * 1994-11-25 1996-12-20 Synthelabo Chlorures de sulfonyles, leur preparation et leur utilisation comme intermediaires de synthese
FR2728570B1 (fr) * 1994-12-23 1997-04-11 Synthelabo Derives de 1-oxo-2-(phenylsulfonylamino)pentylpiperidine, leur preparation et leur application en therapeutique
FR2756285B1 (fr) * 1996-11-22 1998-12-18 Synthelabo Derives de n-(imidazolylbutyle)benzenesulfonamide, leur preparation et leur application en therapeutique
FR2756220B1 (fr) * 1996-11-27 1998-12-24 Lorraine Laminage Roue pour vehicule terrestre a moteur
FR2771094B1 (fr) * 1997-11-19 2000-02-04 Synthelabo Derives de piperidine-2-carboxylate, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
EE05084B1 (et) 2008-10-15
EA004986B1 (ru) 2004-10-28
IS2304B (is) 2007-10-15
EE200200540A (et) 2004-04-15
FR2806722B1 (fr) 2002-05-17
HRP20020762A2 (en) 2003-12-31
PL364988A1 (en) 2004-12-27
JP2003528098A (ja) 2003-09-24
NO20024496D0 (no) 2002-09-19
MEP17408A (en) 2010-06-10
DK1268469T3 (da) 2004-10-11
EP1268469B1 (fr) 2004-06-16
ATE269325T1 (de) 2004-07-15
KR20020081476A (ko) 2002-10-26
IS6535A (is) 2002-08-30
EP1268469A1 (fr) 2003-01-02
US20030207920A1 (en) 2003-11-06
ZA200206996B (en) 2003-09-01
WO2001070736A1 (fr) 2001-09-27
SI1268469T1 (en) 2004-10-31
CA2401637A1 (en) 2001-09-27
IL151619A0 (en) 2003-04-10
AU4661701A (en) 2001-10-03
NO20024496L (no) 2002-11-22
BG65863B1 (bg) 2010-03-31
TR200402343T4 (tr) 2004-12-21
FR2806722A1 (fr) 2001-09-28
ES2222358T3 (es) 2005-02-01
PL204660B1 (pl) 2010-01-29
CN1183128C (zh) 2005-01-05
AU2001246617B2 (en) 2006-03-02
PT1268469E (pt) 2004-10-29
SK286687B6 (sk) 2009-03-05
YU67002A (sh) 2005-07-19
SK13512002A3 (sk) 2003-03-04
NO324835B1 (no) 2007-12-17
BR0109385A (pt) 2003-06-03
HRP20020762B1 (en) 2005-02-28
MXPA02009276A (es) 2003-05-23
EA200200838A1 (ru) 2003-04-24
TWI290141B (en) 2007-11-21
KR100791693B1 (ko) 2008-01-03
US6680329B2 (en) 2004-01-20
AR029900A1 (es) 2003-07-23
DE60103868D1 (de) 2004-07-22
DE60103868T2 (de) 2005-06-09
HUP0300695A2 (hu) 2003-07-28
CN1426407A (zh) 2003-06-25
IL151619A (en) 2009-05-04
CA2401637C (en) 2009-11-10
BG107130A (bg) 2003-06-30
HK1051537A1 (en) 2003-08-08
UA71667C2 (uk) 2004-12-15

Similar Documents

Publication Publication Date Title
CN102482218B (zh) 作为蛋白激酶调节剂的吡啶和吡嗪衍生物
MXPA05000193A (es) Derivados de indol utiles como antagonistas de la histamina h2.
CN103249720A (zh) 作为hdl-胆固醇升高剂的肟化合物
WO2005063709A1 (ja) アミド誘導体及び医薬
WO1999011267A1 (en) Pyrazinone thrombin inhibitors
AU2006200864A1 (en) TNF-alpha production inhibitors
EP1133488A1 (en) Propanoic acid derivatives as integrin inhibitors
EP1334098A2 (en) Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
KR20140049027A (ko) 치환된 헤테로사이클릭 아자 유도체
RS50370B (sr) N-(heterociklil)benzen-ili-piridinsulfonamidi kao antitrombički i antikoagulirajući agensi
EP1663238B1 (en) HEXA- AND OCTAHYDRO-PYRIDO[1,2-a] PYRAZINE DERIVATIVES WITH NK1 ANTAGONISTIC ACTIVITY
CA2844834A1 (en) 5-cycloalkyl- or 5-heterocyclyl-nicotinamides
US20070099927A1 (en) Aminoalkyl-pyrazinones and-pyridones as thrombin inhibitors
US20120094986A1 (en) Anticancer deriviatives, preparation thereof, and therapeutic use thereof
HK1051537B (en) N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants
HK1187912B (en) Oxime compounds as hdl-cholesterol raising agents
HK1193598A (en) 5-cycloalkyl-or 5-heterocyclyl-nicotinamides
HK1193599A1 (en) N-(5-cycloalkyl- or 5-heterocyclyl-)-pyridin-3-yl carboxamides